nodes	percent_of_prediction	percent_of_DWPC	metapath
Dicloxacillin—Tubulointerstitial nephritis—Sorafenib—liver cancer	0.0282	0.0335	CcSEcCtD
Dicloxacillin—Proteinuria—Sorafenib—liver cancer	0.0246	0.0292	CcSEcCtD
Dicloxacillin—Protein urine present—Sorafenib—liver cancer	0.0242	0.0288	CcSEcCtD
Dicloxacillin—Bone disorder—Sorafenib—liver cancer	0.0239	0.0284	CcSEcCtD
Dicloxacillin—Sensitisation—Epirubicin—liver cancer	0.0223	0.0265	CcSEcCtD
Dicloxacillin—Oesophageal ulcer—Epirubicin—liver cancer	0.0219	0.026	CcSEcCtD
Dicloxacillin—Sensitisation—Doxorubicin—liver cancer	0.0207	0.0246	CcSEcCtD
Dicloxacillin—Neurotoxicity—Epirubicin—liver cancer	0.0206	0.0244	CcSEcCtD
Dicloxacillin—Oesophageal ulcer—Doxorubicin—liver cancer	0.0202	0.024	CcSEcCtD
Dicloxacillin—Neurotoxicity—Doxorubicin—liver cancer	0.019	0.0226	CcSEcCtD
Dicloxacillin—Aspartate aminotransferase increased—Sorafenib—liver cancer	0.0141	0.0168	CcSEcCtD
Dicloxacillin—Alanine aminotransferase increased—Sorafenib—liver cancer	0.0138	0.0164	CcSEcCtD
Dicloxacillin—Abdominal discomfort—Sorafenib—liver cancer	0.013	0.0154	CcSEcCtD
Dicloxacillin—Neutropenia—Sorafenib—liver cancer	0.0127	0.015	CcSEcCtD
Dicloxacillin—Renal failure—Sorafenib—liver cancer	0.0119	0.0141	CcSEcCtD
Dicloxacillin—Bone marrow depression—Epirubicin—liver cancer	0.0118	0.014	CcSEcCtD
Dicloxacillin—Stomatitis—Sorafenib—liver cancer	0.0118	0.014	CcSEcCtD
Dicloxacillin—Bone marrow depression—Doxorubicin—liver cancer	0.0109	0.013	CcSEcCtD
Dicloxacillin—SLCO1B1—Recycling of bile acids and salts—NR1H4—liver cancer	0.00992	0.0629	CbGpPWpGaD
Dicloxacillin—Angiopathy—Sorafenib—liver cancer	0.00984	0.0117	CcSEcCtD
Dicloxacillin—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00945	0.0599	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00929	0.0589	CbGpPWpGaD
Dicloxacillin—Bone disorder—Epirubicin—liver cancer	0.00884	0.0105	CcSEcCtD
Dicloxacillin—CYP3A4—Felbamate Metabolism—CYP2E1—liver cancer	0.0088	0.0557	CbGpPWpGaD
Dicloxacillin—Anaemia—Sorafenib—liver cancer	0.00873	0.0104	CcSEcCtD
Dicloxacillin—Angioedema—Sorafenib—liver cancer	0.00863	0.0102	CcSEcCtD
Dicloxacillin—Leukopenia—Sorafenib—liver cancer	0.00845	0.01	CcSEcCtD
Dicloxacillin—Ulcer—Epirubicin—liver cancer	0.00844	0.01	CcSEcCtD
Dicloxacillin—Bone disorder—Doxorubicin—liver cancer	0.00818	0.00971	CcSEcCtD
Dicloxacillin—Myalgia—Sorafenib—liver cancer	0.00804	0.00955	CcSEcCtD
Dicloxacillin—Arthralgia—Sorafenib—liver cancer	0.00804	0.00955	CcSEcCtD
Dicloxacillin—Ulcer—Doxorubicin—liver cancer	0.00781	0.00927	CcSEcCtD
Dicloxacillin—Anaphylactic shock—Sorafenib—liver cancer	0.00771	0.00915	CcSEcCtD
Dicloxacillin—Shock—Sorafenib—liver cancer	0.00758	0.009	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Sorafenib—liver cancer	0.00755	0.00896	CcSEcCtD
Dicloxacillin—Oesophagitis—Epirubicin—liver cancer	0.00729	0.00866	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Sorafenib—liver cancer	0.00702	0.00834	CcSEcCtD
Dicloxacillin—Dyspepsia—Sorafenib—liver cancer	0.00678	0.00805	CcSEcCtD
Dicloxacillin—Oesophagitis—Doxorubicin—liver cancer	0.00675	0.00801	CcSEcCtD
Dicloxacillin—Phlebitis—Epirubicin—liver cancer	0.00673	0.00799	CcSEcCtD
Dicloxacillin—Thrombophlebitis—Epirubicin—liver cancer	0.00669	0.00795	CcSEcCtD
Dicloxacillin—Blood alkaline phosphatase increased—Epirubicin—liver cancer	0.00666	0.00791	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Sorafenib—liver cancer	0.00665	0.0079	CcSEcCtD
Dicloxacillin—Pain—Sorafenib—liver cancer	0.00659	0.00782	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Sorafenib—liver cancer	0.0063	0.00748	CcSEcCtD
Dicloxacillin—Phlebitis—Doxorubicin—liver cancer	0.00622	0.00739	CcSEcCtD
Dicloxacillin—Thrombophlebitis—Doxorubicin—liver cancer	0.00619	0.00735	CcSEcCtD
Dicloxacillin—Blood alkaline phosphatase increased—Doxorubicin—liver cancer	0.00616	0.00732	CcSEcCtD
Dicloxacillin—Urticaria—Sorafenib—liver cancer	0.00612	0.00727	CcSEcCtD
Dicloxacillin—Abdominal pain—Sorafenib—liver cancer	0.00609	0.00723	CcSEcCtD
Dicloxacillin—Body temperature increased—Sorafenib—liver cancer	0.00609	0.00723	CcSEcCtD
Dicloxacillin—Renal impairment—Epirubicin—liver cancer	0.00609	0.00723	CcSEcCtD
Dicloxacillin—Lethargy—Epirubicin—liver cancer	0.00591	0.00702	CcSEcCtD
Dicloxacillin—Hypersensitivity—Sorafenib—liver cancer	0.00568	0.00674	CcSEcCtD
Dicloxacillin—Renal impairment—Doxorubicin—liver cancer	0.00563	0.00669	CcSEcCtD
Dicloxacillin—Lethargy—Doxorubicin—liver cancer	0.00547	0.0065	CcSEcCtD
Dicloxacillin—Pruritus—Sorafenib—liver cancer	0.00545	0.00647	CcSEcCtD
Dicloxacillin—Liver function test abnormal—Epirubicin—liver cancer	0.00535	0.00635	CcSEcCtD
Dicloxacillin—CYP3A4—Liver X Receptor Pathway—SCD—liver cancer	0.00529	0.0335	CbGpPWpGaD
Dicloxacillin—Diarrhoea—Sorafenib—liver cancer	0.00527	0.00626	CcSEcCtD
Dicloxacillin—Aspartate aminotransferase increased—Epirubicin—liver cancer	0.00522	0.0062	CcSEcCtD
Dicloxacillin—SLCO1B1—Bile acid and bile salt metabolism—NR1H4—liver cancer	0.00519	0.0329	CbGpPWpGaD
Dicloxacillin—Alanine aminotransferase increased—Epirubicin—liver cancer	0.00511	0.00607	CcSEcCtD
Dicloxacillin—Eosinophilia—Epirubicin—liver cancer	0.00496	0.00589	CcSEcCtD
Dicloxacillin—Liver function test abnormal—Doxorubicin—liver cancer	0.00495	0.00588	CcSEcCtD
Dicloxacillin—Vomiting—Sorafenib—liver cancer	0.0049	0.00582	CcSEcCtD
Dicloxacillin—Rash—Sorafenib—liver cancer	0.00486	0.00577	CcSEcCtD
Dicloxacillin—Dermatitis—Sorafenib—liver cancer	0.00485	0.00576	CcSEcCtD
Dicloxacillin—Aspartate aminotransferase increased—Doxorubicin—liver cancer	0.00483	0.00573	CcSEcCtD
Dicloxacillin—Pancytopenia—Epirubicin—liver cancer	0.00476	0.00565	CcSEcCtD
Dicloxacillin—Alanine aminotransferase increased—Doxorubicin—liver cancer	0.00473	0.00561	CcSEcCtD
Dicloxacillin—Neutropenia—Epirubicin—liver cancer	0.00468	0.00556	CcSEcCtD
Dicloxacillin—Eosinophilia—Doxorubicin—liver cancer	0.00459	0.00545	CcSEcCtD
Dicloxacillin—Nausea—Sorafenib—liver cancer	0.00458	0.00544	CcSEcCtD
Dicloxacillin—Pancytopenia—Doxorubicin—liver cancer	0.0044	0.00523	CcSEcCtD
Dicloxacillin—Renal failure—Epirubicin—liver cancer	0.00439	0.00521	CcSEcCtD
Dicloxacillin—Stomatitis—Epirubicin—liver cancer	0.00435	0.00517	CcSEcCtD
Dicloxacillin—Neutropenia—Doxorubicin—liver cancer	0.00433	0.00515	CcSEcCtD
Dicloxacillin—Haematuria—Epirubicin—liver cancer	0.00426	0.00506	CcSEcCtD
Dicloxacillin—Agranulocytosis—Epirubicin—liver cancer	0.00417	0.00495	CcSEcCtD
Dicloxacillin—Renal failure—Doxorubicin—liver cancer	0.00406	0.00482	CcSEcCtD
Dicloxacillin—Stomatitis—Doxorubicin—liver cancer	0.00403	0.00478	CcSEcCtD
Dicloxacillin—Haematuria—Doxorubicin—liver cancer	0.00394	0.00468	CcSEcCtD
Dicloxacillin—Agranulocytosis—Doxorubicin—liver cancer	0.00386	0.00458	CcSEcCtD
Dicloxacillin—Angiopathy—Epirubicin—liver cancer	0.00364	0.00432	CcSEcCtD
Dicloxacillin—SLCO1B1—Transport of organic anions—ALB—liver cancer	0.00356	0.0226	CbGpPWpGaD
Dicloxacillin—Flatulence—Epirubicin—liver cancer	0.00344	0.00408	CcSEcCtD
Dicloxacillin—SLCO1B1—Irinotecan Pathway—APC—liver cancer	0.00338	0.0214	CbGpPWpGaD
Dicloxacillin—Angiopathy—Doxorubicin—liver cancer	0.00337	0.004	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Epirubicin—liver cancer	0.00324	0.00384	CcSEcCtD
Dicloxacillin—Anaemia—Epirubicin—liver cancer	0.00323	0.00383	CcSEcCtD
Dicloxacillin—Flatulence—Doxorubicin—liver cancer	0.00318	0.00378	CcSEcCtD
Dicloxacillin—Malaise—Epirubicin—liver cancer	0.00315	0.00374	CcSEcCtD
Dicloxacillin—Leukopenia—Epirubicin—liver cancer	0.00312	0.00371	CcSEcCtD
Dicloxacillin—Convulsion—Epirubicin—liver cancer	0.00302	0.00359	CcSEcCtD
Dicloxacillin—Ill-defined disorder—Doxorubicin—liver cancer	0.003	0.00356	CcSEcCtD
Dicloxacillin—Anaemia—Doxorubicin—liver cancer	0.00298	0.00354	CcSEcCtD
Dicloxacillin—Myalgia—Epirubicin—liver cancer	0.00297	0.00353	CcSEcCtD
Dicloxacillin—Arthralgia—Epirubicin—liver cancer	0.00297	0.00353	CcSEcCtD
Dicloxacillin—Discomfort—Epirubicin—liver cancer	0.00294	0.00349	CcSEcCtD
Dicloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1H4—liver cancer	0.00292	0.0185	CbGpPWpGaD
Dicloxacillin—Malaise—Doxorubicin—liver cancer	0.00291	0.00346	CcSEcCtD
Dicloxacillin—Leukopenia—Doxorubicin—liver cancer	0.00289	0.00343	CcSEcCtD
Dicloxacillin—Confusional state—Epirubicin—liver cancer	0.00287	0.00341	CcSEcCtD
Dicloxacillin—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—liver cancer	0.00287	0.0182	CbGpPWpGaD
Dicloxacillin—Anaphylactic shock—Epirubicin—liver cancer	0.00285	0.00338	CcSEcCtD
Dicloxacillin—Shock—Epirubicin—liver cancer	0.0028	0.00333	CcSEcCtD
Dicloxacillin—Convulsion—Doxorubicin—liver cancer	0.0028	0.00332	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Epirubicin—liver cancer	0.00279	0.00331	CcSEcCtD
Dicloxacillin—Arthralgia—Doxorubicin—liver cancer	0.00275	0.00326	CcSEcCtD
Dicloxacillin—Myalgia—Doxorubicin—liver cancer	0.00275	0.00326	CcSEcCtD
Dicloxacillin—Discomfort—Doxorubicin—liver cancer	0.00272	0.00322	CcSEcCtD
Dicloxacillin—CYP3A4—Farnesoid X Receptor  Pathway—NR1H4—liver cancer	0.00267	0.0169	CbGpPWpGaD
Dicloxacillin—Hypotension—Epirubicin—liver cancer	0.00266	0.00316	CcSEcCtD
Dicloxacillin—Confusional state—Doxorubicin—liver cancer	0.00266	0.00316	CcSEcCtD
Dicloxacillin—SLCO1B1—Recycling of bile acids and salts—ALB—liver cancer	0.00264	0.0167	CbGpPWpGaD
Dicloxacillin—Anaphylactic shock—Doxorubicin—liver cancer	0.00264	0.00313	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Epirubicin—liver cancer	0.00259	0.00308	CcSEcCtD
Dicloxacillin—Shock—Doxorubicin—liver cancer	0.00259	0.00308	CcSEcCtD
Dicloxacillin—Thrombocytopenia—Doxorubicin—liver cancer	0.00258	0.00306	CcSEcCtD
Dicloxacillin—Dyspepsia—Epirubicin—liver cancer	0.00251	0.00298	CcSEcCtD
Dicloxacillin—Hypotension—Doxorubicin—liver cancer	0.00246	0.00292	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Epirubicin—liver cancer	0.00246	0.00292	CcSEcCtD
Dicloxacillin—CYP3A4—Aflatoxin B1 metabolism—GSTM1—liver cancer	0.00245	0.0155	CbGpPWpGaD
Dicloxacillin—Pain—Epirubicin—liver cancer	0.00244	0.00289	CcSEcCtD
Dicloxacillin—Musculoskeletal discomfort—Doxorubicin—liver cancer	0.0024	0.00285	CcSEcCtD
Dicloxacillin—CYP3A4—Estrogen metabolism—GSTA1—liver cancer	0.00235	0.0149	CbGpPWpGaD
Dicloxacillin—Feeling abnormal—Epirubicin—liver cancer	0.00235	0.00279	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Epirubicin—liver cancer	0.00233	0.00277	CcSEcCtD
Dicloxacillin—Dyspepsia—Doxorubicin—liver cancer	0.00232	0.00275	CcSEcCtD
Dicloxacillin—Gastrointestinal disorder—Doxorubicin—liver cancer	0.00227	0.0027	CcSEcCtD
Dicloxacillin—Urticaria—Epirubicin—liver cancer	0.00226	0.00269	CcSEcCtD
Dicloxacillin—Pain—Doxorubicin—liver cancer	0.00225	0.00268	CcSEcCtD
Dicloxacillin—Body temperature increased—Epirubicin—liver cancer	0.00225	0.00267	CcSEcCtD
Dicloxacillin—Abdominal pain—Epirubicin—liver cancer	0.00225	0.00267	CcSEcCtD
Dicloxacillin—Feeling abnormal—Doxorubicin—liver cancer	0.00217	0.00258	CcSEcCtD
Dicloxacillin—Gastrointestinal pain—Doxorubicin—liver cancer	0.00215	0.00256	CcSEcCtD
Dicloxacillin—Hypersensitivity—Epirubicin—liver cancer	0.0021	0.00249	CcSEcCtD
Dicloxacillin—Urticaria—Doxorubicin—liver cancer	0.00209	0.00249	CcSEcCtD
Dicloxacillin—Body temperature increased—Doxorubicin—liver cancer	0.00208	0.00247	CcSEcCtD
Dicloxacillin—Abdominal pain—Doxorubicin—liver cancer	0.00208	0.00247	CcSEcCtD
Dicloxacillin—Pruritus—Epirubicin—liver cancer	0.00201	0.00239	CcSEcCtD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00197	0.0125	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00195	0.0124	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00195	0.0124	CbGpPWpGaD
Dicloxacillin—Diarrhoea—Epirubicin—liver cancer	0.00195	0.00231	CcSEcCtD
Dicloxacillin—Hypersensitivity—Doxorubicin—liver cancer	0.00194	0.00231	CcSEcCtD
Dicloxacillin—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—liver cancer	0.0019	0.012	CbGpPWpGaD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00188	0.0119	CbGpPWpGaD
Dicloxacillin—Pruritus—Doxorubicin—liver cancer	0.00186	0.00221	CcSEcCtD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00183	0.0116	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00181	0.0115	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00181	0.0115	CbGpPWpGaD
Dicloxacillin—Vomiting—Epirubicin—liver cancer	0.00181	0.00215	CcSEcCtD
Dicloxacillin—Diarrhoea—Doxorubicin—liver cancer	0.0018	0.00214	CcSEcCtD
Dicloxacillin—Rash—Epirubicin—liver cancer	0.0018	0.00213	CcSEcCtD
Dicloxacillin—Dermatitis—Epirubicin—liver cancer	0.00179	0.00213	CcSEcCtD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00174	0.011	CbGpPWpGaD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—liver cancer	0.00173	0.0109	CbGpPWpGaD
Dicloxacillin—Nausea—Epirubicin—liver cancer	0.00169	0.00201	CcSEcCtD
Dicloxacillin—Vomiting—Doxorubicin—liver cancer	0.00168	0.00199	CcSEcCtD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1H4—liver cancer	0.00167	0.0106	CbGpPWpGaD
Dicloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—liver cancer	0.00167	0.0106	CbGpPWpGaD
Dicloxacillin—Rash—Doxorubicin—liver cancer	0.00166	0.00197	CcSEcCtD
Dicloxacillin—Dermatitis—Doxorubicin—liver cancer	0.00166	0.00197	CcSEcCtD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—liver cancer	0.00165	0.0104	CbGpPWpGaD
Dicloxacillin—Nausea—Doxorubicin—liver cancer	0.00157	0.00186	CcSEcCtD
Dicloxacillin—CYP3A4—Constitutive Androstane Receptor Pathway—GSTA2—liver cancer	0.00154	0.00976	CbGpPWpGaD
Dicloxacillin—CYP3A4—Xenobiotics—CYP2E1—liver cancer	0.00139	0.00883	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Bile acid and bile salt metabolism—ALB—liver cancer	0.00138	0.00874	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tamoxifen metabolism—CYP2E1—liver cancer	0.00134	0.0085	CbGpPWpGaD
Dicloxacillin—CYP3A4—Aflatoxin activation and detoxification—GGT1—liver cancer	0.00133	0.00845	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transport of vitamins, nucleosides, and related molecules—ALB—liver cancer	0.00132	0.00837	CbGpPWpGaD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—SLC11A2—liver cancer	0.00123	0.00781	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC9C1—liver cancer	0.00122	0.00775	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—MYO5B—liver cancer	0.00122	0.00775	CbGpPWpGaD
Dicloxacillin—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—liver cancer	0.0012	0.00759	CbGpPWpGaD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—SLC40A1—liver cancer	0.00118	0.00745	CbGpPWpGaD
Dicloxacillin—CYP3A4—Estrogen metabolism—GSTM1—liver cancer	0.00115	0.00728	CbGpPWpGaD
Dicloxacillin—CYP3A4—Estrogen metabolism—CYP1A1—liver cancer	0.00109	0.00691	CbGpPWpGaD
Dicloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—NR1H4—liver cancer	0.00106	0.00673	CbGpPWpGaD
Dicloxacillin—CYP3A4—Irinotecan Pathway—APC—liver cancer	0.00104	0.00661	CbGpPWpGaD
Dicloxacillin—CYP3A4—Xenobiotics—CYP1A1—liver cancer	0.001	0.00635	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.001	0.00633	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tamoxifen metabolism—CYP1A1—liver cancer	0.000964	0.0061	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000954	0.00604	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000928	0.00588	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—EPT1—liver cancer	0.000917	0.00581	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000914	0.00579	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000914	0.00579	CbGpPWpGaD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—liver cancer	0.000912	0.00578	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000885	0.00561	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000865	0.00548	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—NR1H4—liver cancer	0.000862	0.00546	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000848	0.00538	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000848	0.00538	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000802	0.00508	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—UGDH—liver cancer	0.000783	0.00496	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tryptophan metabolism—CYP2E1—liver cancer	0.000716	0.00454	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC11A2—liver cancer	0.000627	0.00397	CbGpPWpGaD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—liver cancer	0.000599	0.0038	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—SLC40A1—liver cancer	0.000598	0.00379	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CPT1B—liver cancer	0.000591	0.00374	CbGpPWpGaD
Dicloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—liver cancer	0.000579	0.00367	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ATP7B—liver cancer	0.000573	0.00363	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ANXA2—liver cancer	0.000573	0.00363	CbGpPWpGaD
Dicloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—liver cancer	0.000571	0.00362	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—NR1H4—liver cancer	0.00057	0.00361	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—NR1H4—liver cancer	0.000542	0.00343	CbGpPWpGaD
Dicloxacillin—CYP3A4—Tryptophan metabolism—CYP1A1—liver cancer	0.000515	0.00326	CbGpPWpGaD
Dicloxacillin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—liver cancer	0.000495	0.00314	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—liver cancer	0.000469	0.00297	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—NR1H4—liver cancer	0.000458	0.0029	CbGpPWpGaD
Dicloxacillin—SLC15A2—SLC-mediated transmembrane transport—ALB—liver cancer	0.000453	0.00287	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTA3—liver cancer	0.00045	0.00285	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTA3—liver cancer	0.000444	0.00281	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—CYCS—liver cancer	0.000441	0.00279	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CRABP1—liver cancer	0.000436	0.00276	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—UGDH—liver cancer	0.000434	0.00275	CbGpPWpGaD
Dicloxacillin—SLC15A1—SLC-mediated transmembrane transport—ALB—liver cancer	0.00042	0.00266	CbGpPWpGaD
Dicloxacillin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—liver cancer	0.000416	0.00264	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTA4—liver cancer	0.000412	0.00261	CbGpPWpGaD
Dicloxacillin—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—liver cancer	0.000411	0.0026	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000409	0.00259	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—EPT1—liver cancer	0.000408	0.00259	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTA4—liver cancer	0.000406	0.00257	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTA2—liver cancer	0.000401	0.00254	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—TAT—liver cancer	0.000387	0.00245	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTA1—liver cancer	0.000387	0.00245	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000383	0.00243	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—NAT2—liver cancer	0.000383	0.00242	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—liver cancer	0.000381	0.00241	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—NAT2—liver cancer	0.000377	0.00239	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.000356	0.00225	CbGpPWpGaD
Dicloxacillin—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—liver cancer	0.000337	0.00214	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GPX3—liver cancer	0.000321	0.00203	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—PPARA—liver cancer	0.000309	0.00196	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—HPGDS—liver cancer	0.000306	0.00194	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000287	0.00182	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—GGT1—liver cancer	0.000285	0.00181	CbGpPWpGaD
Dicloxacillin—SLCO1B1—SLC-mediated transmembrane transport—ALB—liver cancer	0.000284	0.0018	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—CYCS—liver cancer	0.000276	0.00175	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GLUL—liver cancer	0.000263	0.00167	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CPT1B—liver cancer	0.000263	0.00167	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NR1H4—liver cancer	0.000254	0.00161	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTA3—liver cancer	0.00025	0.00158	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—CYP2E1—liver cancer	0.000249	0.00158	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—CYP2E1—liver cancer	0.000246	0.00156	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—HMOX1—liver cancer	0.00024	0.00152	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—ALB—liver cancer	0.00023	0.00146	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GGT1—liver cancer	0.000229	0.00145	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTA4—liver cancer	0.000228	0.00145	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—CYP1A1—liver cancer	0.000223	0.00141	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTA2—liver cancer	0.000222	0.00141	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTA1—liver cancer	0.000215	0.00136	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—ALB—liver cancer	0.000213	0.00135	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—NAT2—liver cancer	0.000212	0.00134	CbGpPWpGaD
Dicloxacillin—SLC15A2—Transmembrane transport of small molecules—RAF1—liver cancer	0.000208	0.00132	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTP1—liver cancer	0.000206	0.0013	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARA—liver cancer	0.000204	0.00129	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ALDOB—liver cancer	0.000203	0.00129	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTP1—liver cancer	0.000203	0.00128	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CRABP1—liver cancer	0.000194	0.00123	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—PPARA—liver cancer	0.000194	0.00123	CbGpPWpGaD
Dicloxacillin—SLC15A1—Transmembrane transport of small molecules—RAF1—liver cancer	0.000193	0.00122	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—GSTM1—liver cancer	0.000189	0.0012	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—GSTM1—liver cancer	0.000186	0.00118	CbGpPWpGaD
Dicloxacillin—CYP3A4—Biological oxidations—CYP1A1—liver cancer	0.000179	0.00113	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metapathway biotransformation—CYP1A1—liver cancer	0.000177	0.00112	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CG—liver cancer	0.000175	0.00111	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—HPGDS—liver cancer	0.00017	0.00107	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PPARG—liver cancer	0.000169	0.00107	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CD—liver cancer	0.000154	0.000973	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—liver cancer	0.000152	0.00096	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PSMD10—liver cancer	0.000151	0.000958	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PSMA4—liver cancer	0.000151	0.000958	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GOT2—liver cancer	0.000147	0.000932	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—ALB—liver cancer	0.000144	0.000913	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYP2E1—liver cancer	0.000138	0.000876	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—UGDH—liver cancer	0.000134	0.000849	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CB—liver cancer	0.000134	0.000848	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Transmembrane transport of small molecules—RAF1—liver cancer	0.00013	0.000826	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYCS—liver cancer	0.000129	0.00082	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GOT1—liver cancer	0.000127	0.000804	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GGT1—liver cancer	0.000127	0.000804	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—EPT1—liver cancer	0.000126	0.000798	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—TAT—liver cancer	0.000119	0.000757	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTP1—liver cancer	0.000114	0.000722	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—HMOX1—liver cancer	0.000112	0.000712	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—GSTM1—liver cancer	0.000105	0.000664	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—CYP1A1—liver cancer	9.93e-05	0.000629	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—MTHFR—liver cancer	9.26e-05	0.000587	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PPARA—liver cancer	9.08e-05	0.000576	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—liver cancer	8.16e-05	0.000517	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CPT1B—liver cancer	8.12e-05	0.000514	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GLUL—liver cancer	8.12e-05	0.000514	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NR1H4—liver cancer	7.83e-05	0.000496	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CG—liver cancer	7.78e-05	0.000493	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTA3—liver cancer	7.7e-05	0.000488	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PPARG—liver cancer	7.51e-05	0.000476	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTA4—liver cancer	7.04e-05	0.000446	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTA2—liver cancer	6.86e-05	0.000435	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CD—liver cancer	6.84e-05	0.000433	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—ALB—liver cancer	6.75e-05	0.000428	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTA1—liver cancer	6.62e-05	0.000419	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—NAT2—liver cancer	6.54e-05	0.000415	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ALDOB—liver cancer	6.27e-05	0.000397	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CRABP1—liver cancer	5.98e-05	0.000379	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CB—liver cancer	5.96e-05	0.000378	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—HPGDS—liver cancer	5.23e-05	0.000331	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PSMA4—liver cancer	4.66e-05	0.000295	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PSMD10—liver cancer	4.66e-05	0.000295	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GOT2—liver cancer	4.54e-05	0.000287	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYP2E1—liver cancer	4.26e-05	0.00027	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYCS—liver cancer	3.99e-05	0.000253	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GOT1—liver cancer	3.92e-05	0.000248	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GGT1—liver cancer	3.92e-05	0.000248	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—PIK3CA—liver cancer	3.63e-05	0.00023	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTP1—liver cancer	3.52e-05	0.000223	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—HMOX1—liver cancer	3.47e-05	0.00022	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—GSTM1—liver cancer	3.23e-05	0.000205	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—CYP1A1—liver cancer	3.06e-05	0.000194	CbGpPWpGaD
Dicloxacillin—SLCO1B1—Metabolism—AKT1—liver cancer	2.97e-05	0.000188	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—MTHFR—liver cancer	2.86e-05	0.000181	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PPARA—liver cancer	2.8e-05	0.000178	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CG—liver cancer	2.4e-05	0.000152	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PPARG—liver cancer	2.32e-05	0.000147	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CD—liver cancer	2.11e-05	0.000134	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—ALB—liver cancer	2.08e-05	0.000132	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CB—liver cancer	1.84e-05	0.000116	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—PIK3CA—liver cancer	1.12e-05	7.1e-05	CbGpPWpGaD
Dicloxacillin—CYP3A4—Metabolism—AKT1—liver cancer	9.16e-06	5.8e-05	CbGpPWpGaD
